Home
About
Publications Trends
Recent Publications
Expert Search
Archive
post marketing surveillance
How is PMS Conducted?
Several methods are used to conduct PMS, including:
Spontaneous reporting systems
where healthcare professionals and patients report adverse events
Registry studies
that track the health outcomes of patients over time
Randomized controlled trials
and
observational studies
conducted post-approval
Electronic health records
and pharmacy databases for real-world evidence
Frequently asked queries:
What is Post Marketing Surveillance?
Why is PMS Important for Cancer Drugs?
How is PMS Conducted?
What Are the Challenges in PMS for Cancer Drugs?
What Role Do Patients Play in PMS?
What Are the Benefits of Effective PMS?
What Is the Future of PMS in Cancer Treatment?
What Are Some Challenges of Chaplaincy Programs?
What are pharmaceutical products used in cancer treatment?
How do Resistant Bacteria Impact Cancer Treatment?
What Challenges Do Reviewers Face?
How Can Patients Find Assistance Programs?
What are Gain of Function Mutations?
How Can Technology Aid in Data Integration?
What Are the Economic Benefits of Investing in Cancer Research?
How do Physical Blockers Work?
How Can Data Breaches Impact Cancer Patients?
How Does Probenecid Work?
What Happens After a Security Audit?
What Is the Role of Caregivers in Improving Mobility?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe